Mepiprazole
Anxiolytic drug
| Mepiprazole | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Mepiprazole is a pharmacological compound that was developed as an anxiolytic drug. It belongs to the class of imidazole derivatives and has been studied for its potential effects on anxiety and related disorders.
Chemical Structure[edit]

Mepiprazole is chemically known as 4-methyl-2-(phenylmethyl)-1H-imidazole. The structure consists of an imidazole ring, which is a five-membered ring containing two nitrogen atoms, with a methyl group and a phenylmethyl group attached. This structure is significant as it influences the drug's pharmacological properties and its interaction with biological targets.
Pharmacology[edit]
Mepiprazole acts primarily as an anxiolytic, meaning it is used to reduce anxiety. The exact mechanism of action is not fully understood, but it is believed to involve modulation of neurotransmitter systems in the brain, particularly those involving serotonin and dopamine. These neurotransmitters play a crucial role in mood regulation and anxiety.
Clinical Use[edit]
Mepiprazole was investigated for its potential use in treating anxiety disorders. However, it is not widely used in clinical practice today. The development of newer anxiolytic drugs with more favorable safety profiles and efficacy has overshadowed its use.
Side Effects[edit]
As with many anxiolytic drugs, mepiprazole may cause side effects. Common side effects include drowsiness, dizziness, and nausea. In some cases, more severe side effects such as allergic reactions or cardiovascular issues may occur.
Research and Development[edit]
Research into mepiprazole has provided insights into the development of anxiolytic drugs and the role of imidazole derivatives in pharmacology. Although it is not a major drug in current therapeutic use, it has contributed to the understanding of anxiety treatment.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian